文献速递泌尿男性生殖肿瘤

肥胖依赖的脂肪因子Chemerin抑制脂肪酸氧化赋予ccRCC铁死亡抵抗

Obesity-Dependent Adipokine Chemerin Suppresses Fatty Acid Oxidation to Confer Ferroptosis Resistance.
PubMed 文献 · Cancer Discov · 2021-03-23

该研究在透明细胞肾细胞癌(ccRCC)中发现,肿瘤组织和患者血浆中脂肪因子Chemerin呈肥胖依赖性升高。通过多组学方法揭示Chemerin抑制脂肪酸氧化、阻止铁死亡并维持脂肪酸水平以激活HIF-2α。靶向Chemerin的单克隆抗体可减少脂质储存并抑制肿瘤生长,提示抑制Chemerin具有转化潜力。

要点

  • ccRCC中Chemerin表达呈肥胖依赖性升高,且为肿瘤生物学所必需
  • Chemerin通过抑制脂肪酸氧化和铁死亡维持脂质依赖的HIF-2α表达
  • 靶向Chemerin的单克隆抗体可减少脂质储存并抑制肿瘤生长

核心结论

  • 肥胖和肿瘤细胞通过表达Chemerin促进ccRCC进展,Chemerin在ccRCC生物学中不可或缺。

研究设计与样本

  • 评估ccRCC中脂肪因子表达,采用多种方法减弱Chemerin,并进行多组学分析。

主要发现

  • 肿瘤组织和患者血浆中Chemerin呈肥胖依赖性升高。
  • 减弱Chemerin导致脂质沉积显著减少并损害肿瘤细胞体外和体内生长。
  • Chemerin抑制脂肪酸氧化、阻止铁死亡并维持脂肪酸水平以激活HIF-2α。
  • Chemerin抑制后脂质辅酶Q和线粒体复合物IV生物合成减少,促进脂质活性氧产生。
  • 靶向Chemerin的单克隆抗体减少脂质储存并抑制肿瘤生长。

临床怎么用

  • 抑制Chemerin可能作为ccRCC的潜在治疗策略,尤其针对肥胖相关ccRCC。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Clear cell renal cell carcinoma (ccRCC) is characterized by accumulation of neutral lipids and adipogenic transdifferentiation. We assessed adipokine expression in ccRCC and found that tumor tissues and patient plasma exhibit obesity-dependent elevations of the adipokine chemerin. Attenuation of chemerin by several approaches led to significant reduction in lipid deposition and impairment of tumor cell growth in vitro and in vivo. A multi-omics approach revealed that chemerin suppresses fatty acid oxidation, preventing ferroptosis, and maintains fatty acid levels that activate hypoxia-inducible factor 2α expression. The lipid coenzyme Q and mitochondrial complex IV, whose biogeneses are lipid-dependent, were found to be decreased after chemerin inhibition, contributing to lipid reactive oxygen species production. Monoclonal antibody targeting chemerin led to reduced lipid storage and diminished tumor growth, demonstrating translational potential of chemerin inhibition. Collectively, the results suggest that obesity and tumor cells contribute to ccRCC through the expression of chemerin, which is indispensable in ccRCC biology. SIGNIFICANCE: Identification of a hypoxia-inducible factor-dependent adipokine that prevents fatty acid oxidation and causes escape from ferroptosis highlights a critical metabolic dependency unique in the clear cell subtype of kidney cancer. Targeting lipid metabolism via inhibition of a soluble factor is a promising pharmacologic approach to expand therapeutic strategies for patients with ccRCC.See related commentary by Reznik et al., p. 1879.This article is highlighted in the In This Issue feature, p. 1861.

来源:Cancer Discov,查看原文。版权归原作者所有。

引用

  1. Tan SK, Mahmud I, Fontanesi F, et al. Obesity-Dependent Adipokine Chemerin Suppresses Fatty Acid Oxidation to Confer Ferroptosis Resistance. Cancer Discov. 2021. PMID: 33757970. doi:10.1158/2159-8290.CD-20-1453

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。